Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Maybridge
Maybridge
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Ingredients
Thermo Fisher Scientific introduces ‘off the shelf’ fragment library
Maybridge Ro3 Diversity Fragments now available in prepared stock solution format for convenient use at the bench top
Research & Development
Thermo Fisher to highlight Maybridge solutions at Fragments III
Maybridge scientists to exhibit fragment collections and present research poster
Research & Development
Thermo Fisher Scientific screening collection helps identify promising compound
University of Minnesota Bernlohr Group employs Maybridge HitFinder collection in FABP inhibitor research
Research & Development
Thermo Fisher Scientific screening compound collection goes interactive
Complete Maybridge HitFinder pre-selected diverse screening library now available online
Speed up the drug discovery process with quick building block kits
<p>Maybridge, part of Thermo Fisher Scientific, has introduced a novel tool to accelerate hit-to-lead programmes in the drug discovery process. </p>
Fisher Scientific acquires Maybridge
Maybridge, a leading UK-based supplier of organic compounds and screening libraries, has been acquired by Fisher Scientific International, of the US.
Collaboration on lead optimisation
Subscribe now